India, US signed MoUs to enhance cooperation in areas of Health Sector
The MoUs were signed to enhance cooperation in areas such as cancer research, infrastructure development, training, capacity building and better assessment and application of new diagnostic technologies.
India and the United States (US) on 25 June 2015 signed a series of agreements on health sector to enhance cooperation in areas such as cancer research, infrastructure development, training, capacity building and better assessment and application of new diagnostic technologies.
List of Memorandum of Understanding (MoUs) signed by India and US:
MoU on cancer research, control, prevention and management: Both the countries signed a MoU on collaboration in the areas for conducting research and training on development of low-cost technologies, diagnostics of existing medications against common cancers and development of existing therapies related to oncology.
This MoU was signed among the NCRI (AIIMS), ICMR (DHS), the Department of Biotechnology, (MoST), NCI (NIH) and the US' Department of Health and Human Services (DHHS).
MoU on collaboration in Environmental, occupational Health and Injury Prevention and Control: They also signed an agreement to further the cooperation in education and training, infrastructure development, and capacity-building for their reciprocal and mutual benefit.
The cooperation under the MoU will cover:
• Prevention of illness related to toxic chemicals and hazardous substances
• Development and use of improved tools, technologies and methods for enhancing environmental and occupational public health, and injury prevention efforts, including surveillance
• Focus on public health effects of indoor air pollution including a focus on exposures associated with burning of solid fuels for cooking, prevention of illness and injury related to hazards at the workplace.
Letter of Intent (LoI) on Anti-microbial Resistance Research: A Letter of Intent (LoI) on anti-microbial resistance research was signed between the ICMR, Department of Biotechnology (MoST) and US's National Institute of Allergy and Infectious Diseases, National Institutes of Health and DHHS.
This includes setting up of mechanism of antimicrobial resistance, application of systems biology, comparative testing and assisting the validation of new diagnostics and explore possible patterns of AMR in neonatal intensive care units as observed in India and the US.
The MoUs and LoI were signed by B P Sharma, Secretary Health; K Vijay Raghavan, Secretary Department of Biotechnology under Union Ministry of Science and Technology and Richard Verma, US Ambassador to India.
Now get latest Current Affairs on mobile, Download # 1 Current Affairs App